September 22, 2026From Dosing Strategy to Clinical Benefit: Rethinking Interferon Use Patterns to Optimize Efficacy and Safety
September 22, 2026Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)
September 22, 2026Metformin Alleviates Side Effects and Supports the Resumption of Interferon Therapy in PV and ET
September 22, 2026Myeloproliferative Neoplasm Subtype Impacts Risk of Incident Osteoporosis and Osteoporotic Fractures